Ken Griffin acquired 173 Thousand Intellia Therapeutics shares worth $3.68 Million. That's 0.00% of their equity portfolio (1730th largest holding). The first Intellia Therapeutics trade was made in Q3 2017. Since then Ken Griffin bought shares 38 more times and sold shares on 36 occasions. The investor's estimated purchase price is $8.5 Million, resulting in a loss of 57%.